Linda Wang

Linda is assistant professor in the Division of General Internal Medicine at the Icahn School of Medicine at Mount Sinai. She is a general internist and provides primary care to people who use drugs at the REACH Program, where she also directs the buprenorphine treatment program. She is an active clinician educator who is interested in expanding access to substance use disorder treatment, stigma-free care for people who use drugs and training current and future clinicians in drug-user health.

Biden Is Opposing a Promising Step Toward Buprenorphine Deregulation

In the final week of former President Trump’s term, the US Department of Health and Human services (HHS) announced a…

January 27, 2021